报价延迟最少15分钟:2026/04/02 17:21 EDT
盘后时段
|
||||
|
1.59 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.59
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.14/-0.21
|
|
企业价值
741.88M
|
| 资产负债 |
|
每股账面净值
0.25
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
49.80M
|
|
每股收益
0.00
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic. |
